Novo Nordisk’s new variety of long-lasting insulin, insulin degludec, reduces low blood sugars while improving overall control Novo Nordisk’s new variety of long-lasting insulin, insulin degludec, reduces low blood sugars while improving overall control, according to a pair of studies published in the read more »